ArticleBioengineering (Basel, Switzerland)2026
Biomechanical Evaluation of a Novel Sutureless Hydrogel Device for Peripheral Nerve Repair.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following traumatic injury, nerve repair is essential to the restoration of muscle function and sensation. The current gold standard of nerve repair is microsuture repair, which requires trained microsurgeons to perform time-intensive and technically demanding procedures under high magnification. Microsuture repair suffers from inconsistent repair quality among surgeons and variable clinical outcomes. Neurorrhaphy sutures are non-resorbable and prone to fibrous tissue ingrowth and attendant foreign body reaction, both of which are believed to contribute to the observed shortfall in clinical outcomes. Here, we introduce a novel, sutureless, in situ forming, and fully degradable hydrogel coaptation device for nerve repair. The practical usability of the hydrogel device was assessed by procedure timing, tensile repair strength, and repair quality compared to the traditional microsuture approach. Human cadaveric nerves were used to perform hydrogel and suture repairs for comparison in a relevant model. Additionally, the hydrogel coaptation device was used for primary sciatic nerve repairs in rats to assess feasibility for use in nerve repair in vivo. We observed that hydrogel nerve repairs were performed nearly three times faster than microsuture repairs, without any significant difference in tensile strength when pulled to failure, and had favorable quality scores when blindly assessed by plastic surgeons. Histologically, the in vivo feasibility study showed nerve bridging visualized using H&E, neurofilament, and myelin staining. Our findings suggest the novel hydrogel coaptation device may serve as a potential alternative to suture repair, with features addressing several critical limitations inherent to microsuture and existing nerve repair methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.